✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Melanocortin Receptor Research Peptide
PT-141 is a synthetic peptide studied in laboratory settings for its interaction with melanocortin receptor pathways involved in neuroendocrine signaling. Research commonly examines its receptor-binding activity, downstream signaling effects, and modulation of central nervous system communication in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
PT-141, also known as bremelanotide in scientific literature, is a synthetic peptide analogue derived from melanocortin receptor research. It is developed for controlled laboratory investigation involving melanocortin receptor signaling systems.
In experimental models, PT-141 is studied for its interaction with melanocortin receptors and associated neuroendocrine signaling pathways under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
PT-141 is a synthetic melanocortin receptor agonist evaluated in research focused on melanocortin pathway signaling and neuroendocrine regulatory systems. Experimental studies examine receptor-binding dynamics and downstream signaling frameworks within controlled laboratory environments.
Preclinical and clinical research publications have explored its receptor interaction characteristics and pathway-level signaling mechanisms under structured experimental conditions.
PT-141 originated from investigations into melanocortin receptor agonists derived from α-melanocyte–stimulating hormone (α-MSH) analogues. Research into melanocortin signaling pathways led to the development of synthetic peptides designed to selectively interact with melanocortin receptor subtypes.
Subsequent studies documented its receptor-binding profile and neuroendocrine signaling properties in experimental models.
Laboratory investigations into PT-141 have focused on melanocortin receptor activation models and neuroendocrine signaling pathways. Research frameworks evaluate receptor-mediated interaction, melanocortin pathway dynamics, and regulatory signaling mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized PT-141. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol 134(5):899–908.
PubMedBremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond) 12(3):325–337.
PubMedDouble-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res 16(1):51–59.
PubMedFemale Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
